Karrar SA, Martingano DJ, Hong PL. Preeclampsia [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan– [updated 2024 Feb 25; cited 2025 May 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507639/

Zhang Y, Liu X, Yang L, Zou L. Current researches, rationale, plausibility, and evidence gaps on metformin for the management of hypertensive disorders of pregnancy. Front Pharmacol. 2020;11:596145. https://doi.org/10.3389/fphar.2020.596145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poniedziałek-Czajkowska E, Mierzyński R, Dłuski D, Leszczyńska-Gorzelak B. Prevention of hypertensive disorders of pregnancy—Is there a place for metformin? J Clin Med. 2021;10(13):2805. https://doi.org/10.3390/jcm10132805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett HL, Nitert MD, McIntyre HD, Hague WM, Callaway LK, et al. Predictors of preeclampsia in women in the metformin in gestational diabetes (MiG) study. J Diabetes Metab. 2014;5:395. https://doi.org/10.4172/2155-6156.1000395.

Article  Google Scholar 

Yang Y, Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med. 2022;9:831297. https://doi.org/10.3389/fcvm.2022.831297.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordon H, Salim N, Tong S, Walker S, De Silva M, Cluver C, et al. Metformin use and preeclampsia risk in women with diabetes: a two-country cohort analysis. BMC Med. 2024;22:128. https://doi.org/10.1186/s12916-024-03628-0.

Article  CAS  Google Scholar 

Balani J, Hyer S, Syngelaki A, Akolekar R, Nicolaides KH, Johnson A, et al. Association between insulin resistance and preeclampsia in obese non-diabetic women receiving metformin. Obstet Med. 2017;10(1):1–4. https://doi.org/10.1177/1753495X17725465.

Article  Google Scholar 

Priya G, Kalra S. Metformin in the management of diabetes during pregnancy and lactation. Drugs Context. 2018;7:212523. https://doi.org/10.7573/dic.212523.

Article  PubMed  PubMed Central  Google Scholar 

Corcoran C, Jacobs TF. Metformin [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan– [updated 2023 Aug 17; cited 2025 May 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554054/

Skibińska M, Żurawska-Klis M, Krekora M, Cypryk K. Metformin administration during pregnancy—current insight. Ginekol Pol. 2021;92(1):46–50. https://doi.org/10.5603/GP.a2020.0149.

Article  PubMed  Google Scholar 

Wajid R, Zubair Z, Parveen A, Jamil A, Masood S. Frequency of pre-eclampsia in obese pregnant females taking metformin during pregnancy. P J M H S. 2023;17(3):19–21. https://doi.org/10.53350/pjmhs202317319.

Article  Google Scholar 

Kalafat E, Sukur YE, Abdi A, Thilaganathan B, Khalil A. Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta-analysis of randomized trials. Ultrasound Obstet Gynecol. 2018;52(6):706–14. https://doi.org/10.1002/uog.19084.

Article  CAS  PubMed  Google Scholar 

Hyer S, Balani J, Shehata H. Metformin in pregnancy: mechanisms and clinical applications. Int J Mol Sci. 2018;19(7):1954. https://doi.org/10.3390/ijms19071954.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Racine JL, Adams JH, Antony KM, Iruretagoyena JI, Hoppe KK, Stewart K, et al. Metformin and type 2 diabetes: Could metformin exposure prevent preeclampsia? Am J Obstet Gynecol. 2020;222:S617.

Article  Google Scholar 

Abdel-Aleem H, Shamash A, Abd El-Azeem H, Makhlouf A, Shaaban O. Could metformin be used as a treatment for preeclampsia: a pilot study. J Curr Med Res Pract. 2018;3(1):1–6.

Article  Google Scholar 

Ahmadi S, Salarifar E, Ahmadi K, Rahimi M, Bahraini M. The effect of metformin in preventing superimposed preeclampsia: a randomized clinical trial. J Obstet Gynecol Cancer Res. 2022;7(5):399–404.

Article  Google Scholar 

Cluver CA, Hiscock R, Decloedt EH, Hall DR, Schell S, Mol BW, et al. Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ. 2021;374:n2103. https://doi.org/10.1136/bmj.n2103.

Article  PubMed  PubMed Central  Google Scholar 

Abdalmageed OS, Farghaly TA, Abdelaleem AA, Abdelmagied AE, Ali MK, Abbas AM. Impact of metformin on IVF outcomes in overweight and obese women with polycystic ovary syndrome: a randomized double-blind controlled trial. Reprod Sci. 2019;26(10):1336–42. https://doi.org/10.1177/1933719118765985.

Article  PubMed  Google Scholar 

Brownfoot FC, Hastie R, Hannan NJ, et al. Metformin as a prevention and treatment for preeclampsia: effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction. Am J Obstet Gynecol. 2016;214(3):356.e1-356.e15.

Article  CAS  PubMed  Google Scholar 

Vanky E, Stridsklev S, Heimstad R, Romundstad P, Skogøy K, Kleggetveit O, et al. Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study. J Clin Endocrinol Metab. 2010;95(12):E448–55.

Article  CAS  PubMed  Google Scholar 

Nascimento IB, Dienstmann G, Souza ML, Fleig R, Hoffmann CBP, Silva JC. Evaluation of preeclampsia results after use of metformin in gestation: systematic review and meta-analysis. Rev Bras Ginecol Obstet. 2018;40(12):713–21.

PubMed  PubMed Central  Google Scholar 

Zhu D, Chen Y, Huang J, Deng H, Shen X, Lu D, et al. Effects of metformin on pregnancy outcome, metabolic profile, and sex hormone levels in women with polycystic ovary syndrome and their offspring: a systematic review and meta-analysis. Ann Transl Med. 2022;10(7):418. https://doi.org/10.21037/atm-22-909.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sassin AM, Sangi Haghpeykar H, Aagaard KM. Metformin use and the rates of development of hypertensive disease of pregnancy in gravidae with polycystic ovary syndrome (PCOS). Fertil Steril. 2021;115(1):e53.

Google Scholar 

Tarry-Adkins JL, Ozanne SE, Aiken CE. Impact of metformin treatment during pregnancy on maternal outcomes: a systematic review/meta-analysis. Sci Rep. 2021;11:9240. https://doi.org/10.1038/s41598-021-88650-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiswick C, Denison F, Whyte S, Norman JE, Reynolds RM, Drake AJ, et al. Metformin for the treatment of gestational diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3(9):778–86. https://doi.org/10.1016/S2213-8587(15)00219-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao MZ, Flood Nichols SK, Ahmed M, Clark S, Hankins GD, Caritis S, et al. Effects of pregnancy on the pharmacokinetics of metformin. Drug Metab Dispos. 2020;48(4):264–71. https://doi.org/10.1124/dmd.119.088435.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Syngelaki A, Nicolaides KH, Balani J, Hyer S, Akolekar R, Kotecha R, et al. Metformin versus placebo in obese pregnant women without diabetes mellitus. N Engl J Med. 2016;374(5):434–43. https://doi.org/10.1056/NEJMoa1509819.

Article  CAS  PubMed  Google Scholar 

Fornes R, Simin J, Nguyen MH, Cruz G, Crisosto N, van der Schaaf M, et al. Pregnancy, perinatal and childhood outcomes in women with and without polycystic ovary syndrome and metformin during pregnancy: a nationwide population-based study. Reprod Biol Endocrinol. 2022;20(1):93. https://doi.org/10.1186/s12958-022-00905-6.

Article  CAS  Google Scholar 

Alqudah A, McKinley MC, McNally R, Graham U, Watson CJ, Lyons TJ, et al. The risk of pre-eclampsia in women taking metformin: systematic review and meta-analysis. Diabet Med. 2018;35(2):160–72. https://doi.org/10.1111/dme.13523.

Article  CAS  PubMed  Google Scholar 

Tong S, Kaitu’u-Lino TJ, Hastie R, Brownfoot F, Cluver C, Hannan N. Pravastatin, proton-pump inhibitors, metformin, micronutrients, and biologics: new horizons for the prevention or treatment of preeclampsia. Am J Obstet Gynecol. 2022;226(2S):S1157–70. https://doi.org/10.1016/j.ajog.2020.09.014.

Article  CAS  PubMed  Google Scholar